From professional translators, enterprises, web pages and freely available translation repositories.
albicans isoleret ved baseline).
treatment of azole-susceptible oropharyngeal candidiasis (opc) a randomised, evaluator-blind, controlled study was completed in hiv-infected patients with azole- susceptible oropharyngeal candidiasis (most patients studied had c. albicans isolated at baseline).
2 i kliniske studier var responset på voriconazol 21% lavere hos patienter med infektion med c. glabrata sammenlignet med c. albicans, c. parapsilosis og
2 in clinical studies, response to voriconazole in patients with c. glabrata infections was 21% lower compared to c. albicans, c. parapsilosis and c. tropicalis.
3 i kliniske studier svarede responset på voriconazol hos patienter med infektion med c. krusei til responset ved c. albicans, c. parapsilosis og c. tropicalis.
3 in clinical studies, response to voriconazole in c. krusei infections was similar to c. albicans, c. parapsilosis and c. tropicalis.
anidulafungin udviser in vitro-aktivitet over for c. albicans, c. glabrata, c. parapsilosis, c. krusei og c. tropicalis.
anidulafungin exhibited in-vitro activity against c. albicans, c. glabrata, c. parapsilosis, c. krusei and c. tropicalis.
2 i kliniske forsøg var responset på voriconazol 21% lavere hos patienter med infektion med c. glabrata sammenlignet med c. albicans, c. parapsilosis og c. tropicalis.
2 in clinical studies, response to voriconazole in patients with c glabrata infections was 21% lower compared to c. albicans, c. parapsilosis and c. tropicalis.
in vitro- aktivitet anidulafungin udviser in vitro- aktivitet over for c. albicans, c. glabrata, c. parapsilosis, og c. tropicalis.
activity in vitro anidulafungin exhibited in-vitro activity against c. albicans, c. glabrata, c. parapsilosis, and c. tropicalis.